Radiofrequency ablation: The preferred minimally invasive treatment

Journal of Endourology

Volumn 22, Issue 9, 2008, Pages 1913-1915

  Anderson, J Kyle ^a   Cadeddu, Jeffrey A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CRYOTHERAPY; FEMALE; HUMAN; KIDNEY TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR VOLUME;

AGED; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52449125913     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.9778     Document Type: Conference Paper

References (20)

1. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185:64-71.
2. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: Part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005;185:72-80.
3. Ogan K, Jacomides L, Dolmatch BL, Rivera FJ, Dellaria MF, Josephs SC, Cadeddu JA. Percutaneous radiofrequency ablation of renal tumors: Technique, limitations, and morbidity. Urology 2002;60:954-958.
4. Matsumoto ED, Watumull L, Johnson DB, Ogan K, Taylor GD, Josephs S, Cadeddu JA. The radiographic evolution of radio frequency ablated renal tumors. J Urol 2004;172:45-48.
5. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu J. Radiofrequency ablation of renal tumors: Intermediate-term results. J Endourol 2006;20:569-573.
6. Varkarakis IM, Allaf ME, Inagaki T, et al. Percutaneous radio frequency ablation of renal masses: Results at a 2-year mean followup. J Urol 2005;174:456-460.
7. McDougal WS, Gervais DA, McGovern FJ, et al. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 2005;174:61-63.
8. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163:442-445.
9. Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: Analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 1999;17:2868-2875.
10. Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996;155:1868-1873.
11. Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: A multi-institutional review. J Urol 2004;172:874-877.
12. Johnson DB, Taylor GD, Lotan Y, Sgalowsky AI, Koenemann KS, Cadeddu JA. The effects of radio frequency ablation on renal function and blood pressure. J Urol 2003;170:2234-2336.
13. Mukai T, Sato S, Iguchi T, et al. Effects of radiofrequency ablation on individual renal function: Assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy. Acta Med Okayama 2006;60:85-91.
14. Park S, Dusseault BN, Lotan Y, Pattaras J, Ogan K. Cost analysis for four techniques of renal tumor ablation: Laparoscopic and percutaneous radiofrequency ablation and cryoablation. J Urol 2006:175 (suppl 4):340. Abstract 1060.
15. Rendon RA, Kachura JR, Sweet JM, et al. The uncertainty of radio frequency treatment of renal cell carcinoma: Findings at immediate and delayed nephrectomy. J Urol 2002;167:1587-1592.
16. Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA. Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 2002;168:2406-2410.
17. Coad JE, Kosari K, Humar A, Sielaff TD. Radiofrequency ablation causes "thermal fixation" of hepatocellular carcinoma: A post-liver transplant histopathologic study. Clin Transplant 2003;17:377-384.
18. Anderson JK, Baker M, Jaffers O, Pearle MS, Lindberg GL, Cadeddu JA. Time course of nicotinamide adenine dinucleotide diaphorase staining after renal radiofrequency ablation influences viability assessment. J Endourol 2007;21:223-227.
19. Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC. Phase II trial of radio frequency ablation of renal cancer: Evaluation of the kill zone. J Urol 2002;168:2401-2405.
20. Park S, Strup SE, Saboorian H, Cadeddu JA. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens. Urology 2006;68:964-967.